DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MDM2
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MDM2
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLX-7486
1
Small molecule
Investigational
Unknown
Unknown
Giant Cell Tumors
Macrophage colony stimulating factor receptor inhibitor
PLX-7486
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RALPANCIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Hypercholesterolemia
Subtilisin/kexin type 9 inhibitor
RALPANCIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
YB9L51E4MD
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TERGENPUMATUCEL-L
1
Cell
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
TERGENPUMATUCEL-L
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLUMETINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GLUMETINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
7JTT036WGX
Molecule Type:
Small molecule
Molecular Formula:
C21H17N9O2S
Molecular Weight:
459.5
AlogP:
2.12
PSA:
117.79
HBD:
0.0
HBA:
#RotB:
4.0
Source:
SAMROTAMAB VEDOTIN
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Histiocytoma, Malignant Fibrous
Unknown
SAMROTAMAB VEDOTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
SY5HF6N5MB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CXB722
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CXB722
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABC-008
1
Unknown
Investigational
Unknown
Unknown
Myositis, Inclusion Body
Unknown
ABC-008
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
COCAETHYLENE
1
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders
Unknown
COCAETHYLENE
×
Maximum Phase:
1
First Approval:
None
UNII:
FJO3071W5Y
Molecule Type:
Small molecule
Molecular Formula:
C18H23NO4
Molecular Weight:
317.39
AlogP:
2.26
PSA:
55.84
HBD:
0.0
HBA:
#RotB:
4.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
AMG553
1
Cell
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 binding agent
AMG553
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RINTODESTRANT
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Ductal
Unknown
RINTODESTRANT
×
Maximum Phase:
1
First Approval:
None
UNII:
W3Y784Y0ES
Molecule Type:
Small molecule
Molecular Formula:
C26H19FO5S
Molecular Weight:
462.5
AlogP:
6.48
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LEISH-F3
1
Unknown
Investigational
Unknown
Unknown
Leishmaniasis; Leishmaniasis, Visceral
Unknown
LEISH-F3
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NG-NITRO-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NG-NITRO-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SJ-733
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
SJ-733
×
Maximum Phase:
1
First Approval:
None
UNII:
VT3A7NA96K
Molecule Type:
Small molecule
Molecular Formula:
C24H16F4N4O2
Molecular Weight:
468.41
AlogP:
4.57
PSA:
86.09
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ANSOFAXINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ANSOFAXINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMY-101
1
Protein
Investigational
Unknown
Unknown
Gingivitis
Complement C3 inhibitor
AMY-101
×
Maximum Phase:
1
First Approval:
None
UNII:
4Z4DFR9BX7
Molecule Type:
Protein
Molecular Formula:
C83H117N23O18S2
Molecular Weight:
1789.13
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TEGLARINAD CHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Nicotinamide phosphoribosyltransferase inhibitor
TEGLARINAD CHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
D6V5QYX9MZ
Molecule Type:
Small molecule
Molecular Formula:
C30H43Cl2N5O8
Molecular Weight:
672.61
AlogP:
3.91
PSA:
145.77
HBD:
2.0
HBA:
#RotB:
23.0
Source:
LETRAZURIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LETRAZURIL
×
Maximum Phase:
1
First Approval:
None
UNII:
U8736VCB22
Molecule Type:
Small molecule
Molecular Formula:
C17H9Cl2FN4O2
Molecular Weight:
391.19
AlogP:
3.02
PSA:
91.54
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AMG-820
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasms; Pancreatic Neoplasms
Macrophage colony stimulating factor receptor inhibitor
AMG-820
×
Maximum Phase:
1
First Approval:
None
UNII:
SZ3778HS3S
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04455242
1
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder; Depressive Disorder
Unknown
PF-04455242
×
Maximum Phase:
1
First Approval:
None
UNII:
Y3530Z78QD
Molecule Type:
Small molecule
Molecular Formula:
C21H28N2O2S
Molecular Weight:
372.53
AlogP:
3.88
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
7.0
Source:
E-7130
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E-7130
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C58H83NO17
Molecular Weight:
1066.29
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
IMC-EB10
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid
Tyrosine-protein kinase receptor FLT3 inhibitor
IMC-EB10
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHANE DIMETHANE SULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Renal Cell; Colonic Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin
Unknown
ETHANE DIMETHANE SULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
EW8V7BJ66Q
Molecule Type:
Small molecule
Molecular Formula:
C4H10O6S2
Molecular Weight:
218.25
AlogP:
-1.06
PSA:
86.74
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TIDUTAMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
TIDUTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
88635FW2QX
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KO-539
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
KO-539
×
Maximum Phase:
1
First Approval:
None
UNII:
4MOD1F4ENC
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LODAPOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Pancreatic Neoplasms
Unknown
LODAPOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
NR4MAD6PPB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GUSUIBU
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GUSUIBU
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIAPENEM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
BIAPENEM
×
Maximum Phase:
1
First Approval:
None
UNII:
YR5U3L9ZH1
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O4S
Molecular Weight:
350.4
AlogP:
-1.89
PSA:
102.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
GSK-923295A
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GSK-923295A
×
Maximum Phase:
1
First Approval:
None
UNII:
072702W9QD
Molecule Type:
Small molecule
Molecular Formula:
C32H38ClN5O4
Molecular Weight:
592.14
AlogP:
4.51
PSA:
108.2
HBD:
3.0
HBA:
#RotB:
12.0
Source:
PF-06747143
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
PF-06747143
×
Maximum Phase:
1
First Approval:
None
UNII:
7TS9C20ZWA
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GI HEPTAPEPTIDE
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
GI HEPTAPEPTIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
D33CAJ796A
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PATRITUMAB DERUXTECAN
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
DNA topoisomerase I inhibitor
PATRITUMAB DERUXTECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
3XPI7EG4W8
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
98
99
100
101
102
103
104
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA